9-ING-41 in Patients With Advanced Cancers
Actuate Therapeutics Inc.
Actuate Therapeutics Inc.
Bristol-Myers Squibb
InSightec
Neonc Technologies, Inc.
InSightec
CarThera
AbbVie
Blueprint Medicines Corporation
Novartis
Xennials Therapeutics Australia Pty Ltd
CarThera
Novartis
MedImmune LLC
Eli Lilly and Company
Gilead Sciences
Myrexis Inc.